InvestorsHub Logo
Followers 2
Posts 62
Boards Moderated 0
Alias Born 07/02/2013

Re: blakemartin2014 post# 9839

Thursday, 06/04/2020 11:01:07 PM

Thursday, June 04, 2020 11:01:07 PM

Post# of 16707
I could also be wrong but I agree with that sentiment and "felt like" (notice I said felt like, and didn't cite any sources) I heard the same thing. I think CEO said because it's an IND, depending on 2b, the length of time/size phase 3 is needed before approval is much different than the typical route of a brand new drug.

The 2022 date to me just seems like a safety buffer because a date is "needed".